Apollo Hospitals share price tumble over 6.5% amid profit booking after Q3 earnings

During the intraday trade, the company was trading at ₹6,344.20 apiece on BSE, tanking 6.23%.

Apollo Hospitals’ consolidated profit increased 51.8% year-on-year (YoY) to ₹372.3 crore in Q3FY25, from ₹245.3 crore in the same quarter previous fiscal year.

Its revenue from operations climbed 13.9% YoY to ₹5,526.9 crore in Q3FY25, from ₹4,850.6 crore in Q3FY24.

The healthcare provider is on track to add 3,512 beds over 11 locations in a period spanning 3-4 years, beginning FY26, it added.

Apollo Hospitals' earnings before interest, tax, depreciation, and amortisation (EBITDA) also soared 24.1% YoY to ₹761.5 crore in Q3FY25, from ₹613.7 crore a year ago. Subsequently, its EBITDA margin expanded to 110 basis points (bps) 13.8% in Q3FY25, from 12.7% a year ago.

"The results reflect our growth story that underlines our purpose of healing India and touching more than a billion lives. From Mumbai to Varanasi and Chennai to Gurugram, we are committed to ensuring that quality healthcare is not a privilege but a fundamental right for all," Apollo Hospitals Enterprise Chairman Prathap C Reddy said.

The company's strategic partnership with Microsoft is accelerating Al-driven healthcare transformation, including innovation in disease progression and genomics, he added.

By collaborating with the University of Leicester, Apollo is equipping the next generation of healthcare professionals with unmatched skills, Reddy said.

The company said its board declared an interim dividend of ₹9 per share (180% of face value of ₹5 each) for the financial year ending March 31, 2025.

The board has fixed the record date as February 15, 2025, for the purpose of payment of the interim dividend, it added.

Apollo Hospitals is Asia’s foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies, Primary Care & Diagnostic Clinics and several retail health models.